US Stock MarketDetailed Quotes

CLAZF CLARITAS PHARMACEUTICALS INC

Watchlist

0.000
0.0000.00%

15min DelayClose Aug 30 16:00 ET

36.59Market Cap0.00P/E (TTM)

CLARITAS PHARMACEUTICALS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-37.47%514K

49.18%549K

-71.35%159K

-101.95%-184K

-418.47%-1.71M

-62.24%822K

-88.28%368K

-84.58%555K

-14.87%9.45M

-83.65%536K

Selling and administrative expenses

-37.47%514K

49.18%549K

-55.59%159K

-48.89%1.87M

-27.65%348K

-27.89%822K

-71.07%368K

-53.39%358K

9.22%3.66M

-51.51%481K

-General and administrative expense

-37.47%514K

49.18%549K

-55.59%159K

-48.89%1.87M

-27.65%348K

-27.89%822K

-71.07%368K

-53.39%358K

9.22%3.66M

-51.51%481K

Research and development costs

----

--0

-135.49%-2.06M

----

-93.04%197K

-25.29%5.79M

-97.59%55K

Operating profit

37.47%-514K

-49.18%-549K

71.35%-159K

101.95%184K

418.47%1.71M

62.24%-822K

88.28%-368K

84.58%-555K

14.87%-9.45M

83.65%-536K

Net non-operating interest income expense

-21.02%695K

-79.20%-715K

-100.90%-20K

-6.27%-271K

-248.40%-2.94M

48.40%880K

-188.86%-399K

586.78%2.21M

4.85%-255K

-1,417.19%-843K

Non-operating interest income

-31.30%709K

--0

-98.28%39K

----

63.03%1.03M

--0

--2.26M

----

Non-operating interest expense

-90.79%14K

79.20%715K

15.69%59K

7.66%225K

80.77%-20K

280.00%152K

102.54%399K

-88.77%51K

36.60%209K

41.90%-104K

Total other finance cost

----

0.00%46K

----

-60.00%46K

----

Other net income (expense)

-121.16%-2.6M

96.36%-587K

655.52%12.28M

-188.59%-16.13M

-213.27%-7.11M

Gain on sale of security

----

502.31%2.87M

----

-96.64%477K

----

Special income (charges)

----

-121.16%-2.6M

79.16%-3.46M

----

655.52%12.28M

-512.96%-16.61M

-264.26%-7.59M

-Less：Restructuring and merger&acquisition

----

100.45%55K

29.83%-12.17M

----

-541.75%-12.34M

-166.26%-17.34M

-199.19%-3.07M

-Less:Impairment of capital assets

----

4,068.85%2.54M

-53.71%15.63M

----

110.46%61K

1,254.55%33.77M

235.81%10.48M

-Write off

----

--0

----

--180K

----

Income before tax

212.07%181K

-64.80%-1.26M

-119.93%-2.78M

97.39%-674K

78.60%-1.82M

112.89%58K

92.78%-767K

322.45%13.93M

-477.91%-25.83M

-377.03%-8.49M

Income tax

-4,227.27%-476K

-5.67%-4.88M

-69,671.43%-4.88M

-108.40%-11K

-4,568.69%-4.62M

-100.37%-7K

Net income

143.83%181K

77.57%-1.94M

-116.50%-2.3M

119.85%4.21M

92.29%-654K

57.68%-413K

-61.74%-8.67M

318.06%13.94M

-405.87%-21.21M

-822.04%-8.48M

Net income continuous Operations

212.07%181K

-64.80%-1.26M

-116.50%-2.3M

119.85%4.21M

136.15%3.07M

105.94%58K

85.68%-767K

318.06%13.94M

-405.87%-21.21M

-822.04%-8.48M

Net income discontinuous operations

--0

91.39%-680K

----

---471K

---7.9M

----

Minority interest income

Net income attributable to the parent company

143.83%181K

77.57%-1.94M

-116.50%-2.3M

119.85%4.21M

92.29%-654K

57.68%-413K

-61.74%-8.67M

318.06%13.94M

-405.87%-21.21M

-822.04%-8.48M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

143.83%181K

77.57%-1.94M

-116.50%-2.3M

119.85%4.21M

92.29%-654K

57.68%-413K

-61.74%-8.67M

318.06%13.94M

-405.87%-21.21M

-822.04%-8.48M

Basic earnings per share

103.01%0.0051

98.06%-0.0582

-113.93%-0.0836

116.00%0.16

95.00%-0.02

-325.00%-0.17

-1,400.00%-3

242.86%0.6

-225.00%-1

-300.00%-0.4

Diluted earnings per share

103.01%0.0051

98.06%-0.0582

-113.93%-0.0836

116.00%0.16

95.00%-0.02

-325.00%-0.17

-1,400.00%-3

242.86%0.6

-600.00%-1

-558.82%-0.4

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-37.47%514K	49.18%549K	-71.35%159K	-101.95%-184K	-418.47%-1.71M	-62.24%822K	-88.28%368K	-84.58%555K	-14.87%9.45M	-83.65%536K
Selling and administrative expenses	-37.47%514K	49.18%549K	-55.59%159K	-48.89%1.87M	-27.65%348K	-27.89%822K	-71.07%368K	-53.39%358K	9.22%3.66M	-51.51%481K
-General and administrative expense	-37.47%514K	49.18%549K	-55.59%159K	-48.89%1.87M	-27.65%348K	-27.89%822K	-71.07%368K	-53.39%358K	9.22%3.66M	-51.51%481K
Research and development costs	----	----	--0	-135.49%-2.06M	----	----	----	-93.04%197K	-25.29%5.79M	-97.59%55K
Operating profit	37.47%-514K	-49.18%-549K	71.35%-159K	101.95%184K	418.47%1.71M	62.24%-822K	88.28%-368K	84.58%-555K	14.87%-9.45M	83.65%-536K
Net non-operating interest income expense	-21.02%695K	-79.20%-715K	-100.90%-20K	-6.27%-271K	-248.40%-2.94M	48.40%880K	-188.86%-399K	586.78%2.21M	4.85%-255K	-1,417.19%-843K
Non-operating interest income	-31.30%709K	--0	-98.28%39K	----	----	63.03%1.03M	--0	--2.26M	----	----
Non-operating interest expense	-90.79%14K	79.20%715K	15.69%59K	7.66%225K	80.77%-20K	280.00%152K	102.54%399K	-88.77%51K	36.60%209K	41.90%-104K
Total other finance cost	----	----	----	0.00%46K	----	----	----	----	-60.00%46K	----
Other net income (expense)			-121.16%-2.6M	96.36%-587K				655.52%12.28M	-188.59%-16.13M	-213.27%-7.11M
Gain on sale of security	----	----	----	502.31%2.87M	----	----	----	----	-96.64%477K	----
Special income (charges)	----	----	-121.16%-2.6M	79.16%-3.46M	----	----	----	655.52%12.28M	-512.96%-16.61M	-264.26%-7.59M
-Less：Restructuring and merger&acquisition	----	----	100.45%55K	29.83%-12.17M	----	----	----	-541.75%-12.34M	-166.26%-17.34M	-199.19%-3.07M
-Less:Impairment of capital assets	----	----	4,068.85%2.54M	-53.71%15.63M	----	----	----	110.46%61K	1,254.55%33.77M	235.81%10.48M
-Write off	----	----	----	--0	----	----	----	----	--180K	----
Income before tax	212.07%181K	-64.80%-1.26M	-119.93%-2.78M	97.39%-674K	78.60%-1.82M	112.89%58K	92.78%-767K	322.45%13.93M	-477.91%-25.83M	-377.03%-8.49M
Income tax	0	0	-4,227.27%-476K	-5.67%-4.88M	-69,671.43%-4.88M	0	0	-108.40%-11K	-4,568.69%-4.62M	-100.37%-7K
Net income	143.83%181K	77.57%-1.94M	-116.50%-2.3M	119.85%4.21M	92.29%-654K	57.68%-413K	-61.74%-8.67M	318.06%13.94M	-405.87%-21.21M	-822.04%-8.48M
Net income continuous Operations	212.07%181K	-64.80%-1.26M	-116.50%-2.3M	119.85%4.21M	136.15%3.07M	105.94%58K	85.68%-767K	318.06%13.94M	-405.87%-21.21M	-822.04%-8.48M
Net income discontinuous operations	--0	91.39%-680K	----	----	----	---471K	---7.9M	----	----	----
Minority interest income
Net income attributable to the parent company	143.83%181K	77.57%-1.94M	-116.50%-2.3M	119.85%4.21M	92.29%-654K	57.68%-413K	-61.74%-8.67M	318.06%13.94M	-405.87%-21.21M	-822.04%-8.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	143.83%181K	77.57%-1.94M	-116.50%-2.3M	119.85%4.21M	92.29%-654K	57.68%-413K	-61.74%-8.67M	318.06%13.94M	-405.87%-21.21M	-822.04%-8.48M
Basic earnings per share	103.01%0.0051	98.06%-0.0582	-113.93%-0.0836	116.00%0.16	95.00%-0.02	-325.00%-0.17	-1,400.00%-3	242.86%0.6	-225.00%-1	-300.00%-0.4
Diluted earnings per share	103.01%0.0051	98.06%-0.0582	-113.93%-0.0836	116.00%0.16	95.00%-0.02	-325.00%-0.17	-1,400.00%-3	242.86%0.6	-600.00%-1	-558.82%-0.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data